首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
optic glioma相关文献:
Optic pathway glioma of childhood.
Rasool N, Odel JG, Kazim M.
Curr Opin Ophthalmol. 2017 May;28(3):289-295. doi: 10.1097/ICU.0000000000000370.
PMID:28257299
Optic nerve glioma: an update.
Nair AG, Pathak RS, Iyer VR, Gandhi RA.
Int Ophthalmol. 2014 Aug;34(4):999-1005. doi: 10.1007/s10792-014-9942-8. Epub 2014 Apr 16.
PMID:24736941
The Present and Future of Optic Pathway Glioma Therapy.
Dal Bello S, Martinuzzi D, Tereshko Y, Veritti D, Sarao V, Gigli GL, Lanzetta P, Valente M.
Cells. 2023 Sep 29;12(19):2380. doi: 10.3390/cells12192380.
PMID:37830595
Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.
Freret ME, Gutmann DH.
J Neurosci Res. 2019 Jan;97(1):45-56. doi: 10.1002/jnr.24250. Epub 2018 Apr 28.
PMID:29704429
Endoscopic debulking canalization for optic pathway glioma with obstructive hydrocephalus.
Takeuchi K, Ohka F, Nagata Y, Ito E, Harada H, Saito R.
Childs Nerv Syst. 2023 Dec;39(12):3421-3425. doi: 10.1007/s00381-023-06053-5. Epub 2023 Jun 26.
PMID:37365300
An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies.
Chen Y, Yu J, Ge S, Jia R, Song X, Wang Y, Fan X.
Invest Ophthalmol Vis Sci. 2024 Jun 3;65(6):8. doi: 10.1167/iovs.65.6.8.
PMID:38837168
Optic nerve glioma.
Cirak B.
J Neurosurg. 2003 Sep;99(2 Suppl):246; author reply 246. doi: 10.3171/spi.2003.99.2.0246.
PMID:12956473
Hypofractionated stereotactic irradiation for optic nerve glioma.
Zagirov RI, Trunin YY, Serova NK, Pronin IN, Antipina NA, Golanov AV.
Zh Vopr Neirokhir Im N N Burdenko. 2022;86(5):74-80. doi: 10.17116/neiro20228605174.
PMID:36252196
Optic pathway-hypothalamic glioma hemorrhage: a series of 9 patients and review of the literature.
van Baarsen K, Roth J, Serova N, Packer RJ, Shofty B, Thomale UW, Cinalli G, Toledano H, Michowiz S, Constantini S.
J Neurosurg. 2018 Dec 1;129(6):1407-1415. doi: 10.3171/2017.8.JNS163085.
PMID:29424646
Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature.
Friedrich RE, Nuding MA.
Anticancer Res. 2016 Aug;36(8):4095-121.
PMID:27466519
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3